NCT07679919 clinical trial report covering LMY-922, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

NCT07679334 clinical trial report covering Pacritinib, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

CTR20262505 clinical trial report covering NTQ5082, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

CTR20262423 clinical trial report covering Alpha-0261, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

CTR20262530 clinical trial report covering Girocitinib, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

NCT07681479 clinical trial report covering HRS-9057, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

CTR20262554 clinical trial report covering HWS-113, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

NCT07681882 clinical trial report covering DS1025a, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

CTR20262553 clinical trial report covering SN007, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

CTR20262568 clinical trial report covering LNF2401, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

ChiCTR2600127634 clinical trial report covering Toripalimab, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

CTR20262577 clinical trial report covering Ammoxetine Hydrochloride, Phase 1, endpoints, sponsor, geography, readout timing and development white space.